NovoCure

NovoCure, incorporated in 2000, is a healthcare company with headquarters in Saint Helier, Jersey. It specializes in the oncology sector, focusing on developing, manufacturing, and commercializing devices that treat cancer through the use of Tumor Treating Fields (TTFields). Their prime brand, Optune, is a non-invasive, portable device created to deliver TTFields to the body area affected by a malignant tumor, mainly targeting glioblastoma, which is a form of brain cancer. NovoCure's products and services have a global footprint with key markets in the United States, Germany, and Japan. The company also markets its devices in additional European countries, select Asian territories, and continues to expand into new international markets. (Powered by AI)